Encompass Health Corporation EHC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 10%+0.5pp | 9.5%+0.2pp | 9.3%+0.1pp | 9.2%+0.2pp | 9%+0.5pp | |
| Returns | ||||||
| Return on equity | 26%+0.9pp | 25.1%+0.2pp | 25%-0.4pp | 25.4%0.0pp | 25.4%+0.8pp | |
| Return on invested capital | 16.7%+0.4pp | 16.3%+0.5pp | 15.8%+0.2pp | 15.6%+0.4pp | 15.2%+1.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.1× | 1.1×-0.1× | 1.1×+0.1× | 1.1×0.0× | 1.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×0.0× | 1.3×0.0× | 1.3×-0.1× | 1.4×-0.1× | 1.5×-0.1× | |
| Net debt / EBITDA | 2×-0.1× | 2.1×-0.1× | 2.2×-0.1× | 2.3×-0.1× | 2.4×-0.1× | |
| Per Share | ||||||
| Book value per share | $25.07+5.1% | $23.86+2.8% | $23.20+4.1% | $22.29+5.4% | $21.15+4.6% | |
| Valuation | ||||||
| Market capitalization | $9.62B-10.0% | $10.68B-16.5% | $12.79B+5.0% | $12.19B+19.5% | $10.2B+9.6% | |
| Price / earnings | 15.8×-3.1× | 18.9×-4.8× | 23.6×+0.3× | 23.3×+2.7× | 20.6×+0.2× | |
| Price / sales | 1.6×-0.2× | 1.8×-0.4× | 2.2×+0.1× | 2.2×+0.3× | 1.9×+0.1× | |
| Price / book | 3.8×-0.6× | 4.4×-1.0× | 5.4×0.0× | 5.3×+0.6× | 4.7×+0.2× | |
| EV / EBITDA | 8.6×-1.1× | 9.7×-2.0× | 11.7×+0.1× | 11.6×+1.1× | 10.6×+0.2× | |
| Dividend yield | 0.8%+0.1pp | 0.7%+0.1pp | 0.5%0.0pp | 0.6%-0.1pp | 0.6%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Encompass Health Corporation's ratios come from?
- Every ratio is computed from Encompass Health Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
